CSF-CXCL13 is discussed to be a helpful diagnostic biomarker together with CXCL9, β2-microglobulin, soluble interleukin-2-receptor, and interleukin-10 in CNS lymphoma [59,60,61]. The gene discussed is CXCL9; the disease is primary central nervous system lymphoma.